Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer By Ogkologos - October 14, 2025 360 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ROME study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Our nurses answer your frequently asked questions about cancer March 2, 2023 Adding Gemcitabine to Cisplatin Once per Week Concurrently with IMRT Significantly... April 17, 2024 Novel Checklist for Quality of Life to Bring ESMO-MCBS and Clinical... December 20, 2022 Darolutamide Delays the Spread of Some Prostate Cancers March 15, 2019 Load more HOT NEWS Apalutamide Plus ADT Demonstrates a Rapid, Deep, and Durable PSA Decline... After Struggling With Chronic Illnesses Most of Her Life, This Author... Man Met A Stranger At A Bar Who Was In Need... Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy
